With the shift toward de-escalating surgery in breast cancer, prediction models incorporating imaging can reassess the need for surgical axillary staging. This study employed advancements in deep learning to comprehensively evaluate routine mammograms for…
Continue Reading
Revolutionary FDA Approval Marks Medical Milestone
Startup Clairity has achieved a groundbreaking milestone in healthcare technology, securing FDA approval for the agency’s first artificial intelligence tool specifically designed to predict five-year breast cancer risk from…
Source Credit: freepik
What You Should Know:
– Artificial intelligence (AI) could play a crucial role in identifying breast cancers that develop between routine screening mammograms, potentially detecting them before they become more advanced and challenging…
Continue Reading
Dr. Bernard Schayes, a New York City-based physician in private practice with the Mount Sinai IPA and Northwell Health IPA, struggled with meeting the challenges in adopting value-based care.THE CHALLENGE
Ensuring patients stayed up to…
Study Reveals Critical Diversity Gaps
A concerning study published in the European Journal of Cancer highlights significant diversity problems in AI mammogram interpretation datasets. Researchers discovered that racial, ethnic, and geographic representation is severely lacking,…
According to a study published in the European Journal of Cancer, the fairness and equity of datasets for AI-driven mammogram interpretation might be jeopardized by the underrepresentation of racial and ethnic diversity.While AI shows…
Continue Reading
Strategic Acquisition Enhances AI Capabilities
ScreenPoint Medical’s acquisition of Biomediq A/S on January 8, 2025, represents a milestone in AI-driven breast cancer detection. This strategic merger follows ten years of collaborative research, integrating Biomediq’s quantitative…
What You Should Know:
– ScreenPoint Medical, a provider of AI-powered breast cancer screening solutions, acquires Biomediq A/S, a research-based company specializing in quantitative imaging biomarkers. Financial details of the acquisition were not disclosed.
– ScreenPoint’s…
Continue Reading
What You Should Know:
– MICA Artificial Intelligence and Baptist Health South Florida have joined forces in a groundbreaking collaboration to transform breast cancer detection.
– By integrating MICA AI’s innovative technology into mammography, the partnership…
Continue Reading
What You Should Know:
– CureMetrix, an innovator in AI-driven mammography solutions, has partnered with SimonMed Imaging, a prominent provider of outpatient medical imaging services in the United States.
– The strategic collaboration will bring CureMetrix’s…
Continue Reading
